125 related articles for article (PubMed ID: 38452616)
21. Establishment of a novel culture method for maintaining intestinal stem cells derived from human induced pluripotent stem cells.
Kondo S; Mizuno S; Hashita T; Iwao T; Matsunaga T
Biol Open; 2020 Jan; 9(1):. PubMed ID: 31919043
[TBL] [Abstract][Full Text] [Related]
22. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
[TBL] [Abstract][Full Text] [Related]
23. Generation of Human-Induced Pluripotent Stem Cell-Derived Functional Enterocyte-Like Cells for Pharmacokinetic Studies.
Yoshida S; Honjo T; Iino K; Ishibe R; Leo S; Shimada T; Watanabe T; Ishikawa M; Maeda K; Kusuhara H; Shiraki N; Kume S
Stem Cell Reports; 2021 Feb; 16(2):295-308. PubMed ID: 33513361
[TBL] [Abstract][Full Text] [Related]
24. Protective Effect of Irsogladine against Aspirin-Induced Mucosal Injury in Human Induced Pluripotent Stem Cell-Derived Small Intestine.
Kanno T; Katano T; Ogawa I; Iwao T; Matsunaga T; Kataoka H
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676718
[No Abstract] [Full Text] [Related]
25. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells.
Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB
Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292
[TBL] [Abstract][Full Text] [Related]
26. Modeling of drug-mediated CYP3A4 induction by using human iPS cell-derived enterocyte-like cells.
Negoro R; Takayama K; Nagamoto Y; Sakurai F; Tachibana M; Mizuguchi H
Biochem Biophys Res Commun; 2016 Apr; 472(4):631-6. PubMed ID: 26966071
[TBL] [Abstract][Full Text] [Related]
27. Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine.
Akazawa T; Yoshida S; Ohnishi S; Kanazu T; Kawai M; Takahashi K
Drug Metab Dispos; 2018 Nov; 46(11):1497-1506. PubMed ID: 30135242
[TBL] [Abstract][Full Text] [Related]
28. Generation of Budding-Like Intestinal Organoids from Human Induced Pluripotent Stem Cells.
Onozato D; Ogawa I; Kida Y; Mizuno S; Hashita T; Iwao T; Matsunaga T
J Pharm Sci; 2021 Jul; 110(7):2637-2650. PubMed ID: 33794275
[TBL] [Abstract][Full Text] [Related]
29. Influences of cytochrome b5 expression and its genetic variant on the activity of CYP2C9, CYP2C19 and CYP3A4.
Yoo SE; Yi M; Kim WY; Cho SA; Lee SS; Lee SJ; Shin JG
Drug Metab Pharmacokinet; 2019 Jun; 34(3):201-208. PubMed ID: 30992242
[TBL] [Abstract][Full Text] [Related]
30. Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra-subject analysis.
Fritz A; Busch D; Lapczuk J; Ostrowski M; Drozdzik M; Oswald S
Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):245-255. PubMed ID: 30253071
[TBL] [Abstract][Full Text] [Related]
31. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.
Yamazaki H; Shimada T
Arch Biochem Biophys; 1997 Oct; 346(1):161-9. PubMed ID: 9328296
[TBL] [Abstract][Full Text] [Related]
32. Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine.
Clermont V; Grangeon A; Barama A; Turgeon J; Lallier M; Malaise J; Michaud V
Br J Clin Pharmacol; 2019 Jun; 85(6):1367-1377. PubMed ID: 30817016
[TBL] [Abstract][Full Text] [Related]
33. Cytochrome P450-Catalyzed Metabolism of Cannabidiol to the Active Metabolite 7-Hydroxy-Cannabidiol.
Beers JL; Fu D; Jackson KD
Drug Metab Dispos; 2021 Oct; 49(10):882-891. PubMed ID: 34330718
[TBL] [Abstract][Full Text] [Related]
34. Quantitative Prediction of Intestinal Absorption of Drugs from In Vitro Study: Utilization of Differentiated Intestinal Epithelial Cells Derived from Intestinal Stem Cells at Crypts.
Maeda K
Drug Metab Dispos; 2023 Sep; 51(9):1136-1144. PubMed ID: 37142427
[TBL] [Abstract][Full Text] [Related]
35. Retinoic acid promotes barrier functions in human iPSC-derived intestinal epithelial monolayers.
Yamada S; Kanda Y
J Pharmacol Sci; 2019 Aug; 140(4):337-344. PubMed ID: 31399314
[TBL] [Abstract][Full Text] [Related]
36. Establishment of human intestinal organoids derived from commercially available cryopreserved intestinal epithelium and evaluation for pharmacokinetic study.
Okada K; Yokota J; Yamashita T; Inui T; Kishimoto W; Nakase H; Mizuguchi H
Drug Metab Pharmacokinet; 2024 Feb; 54():100532. PubMed ID: 38064926
[TBL] [Abstract][Full Text] [Related]
37. Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers.
Yeh RF; Gaver VE; Patterson KB; Rezk NL; Baxter-Meheux F; Blake MJ; Eron JJ; Klein CE; Rublein JC; Kashuba AD
J Acquir Immune Defic Syndr; 2006 May; 42(1):52-60. PubMed ID: 16639344
[TBL] [Abstract][Full Text] [Related]
38. Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research.
Inui T; Uraya Y; Yokota J; Yamashita T; Kawai K; Okada K; Ueyama-Toba Y; Mizuguchi H
Stem Cell Res Ther; 2024 Feb; 15(1):57. PubMed ID: 38424603
[TBL] [Abstract][Full Text] [Related]
39. Drinking Ethanol Has Few Acute Effects on CYP2C9, CYP2C19, NAT2, and P-Glycoprotein Activities but Somewhat Inhibits CYP1A2, CYP2D6, and Intestinal CYP3A: So What?
Gazzaz M; Kinzig M; Schaeffeler E; Jübner M; Hsin CH; Li X; Taubert M; Trueck C; Iltgen-Breburda J; Kraus D; Queckenberg C; Stoffel M; Schwab M; Sörgel F; Fuhr U
Clin Pharmacol Ther; 2018 Dec; 104(6):1249-1259. PubMed ID: 29633238
[TBL] [Abstract][Full Text] [Related]
40. 3D Spheroid Primary Human Hepatocytes for Prediction of Cytochrome P450 and Drug Transporter Induction.
Järvinen E; Hammer HS; Pötz O; Ingelman-Sundberg M; Stage TB
Clin Pharmacol Ther; 2023 Jun; 113(6):1284-1294. PubMed ID: 36906857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
